Duopharma Biotech Bhd - Asset Resilience Ratio

Latest as of September 2025: 18.52%

Duopharma Biotech Bhd (7148) has an Asset Resilience Ratio of 18.52% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Duopharma Biotech Bhd debt and liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

RM268.67 Million
≈ $67.45 Million USD Cash + Short-term Investments

Total Assets

RM1.45 Billion
≈ $364.26 Million USD All company assets

Resilience Assessment

Good
Financial Resilience Level

Asset Resilience Ratio Trend (2016–2024)

This chart shows how Duopharma Biotech Bhd's Asset Resilience Ratio has changed over time. See 7148 net asset value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Duopharma Biotech Bhd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 7148 market cap.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents RM268.67 Million 18.52%
Short-term Investments RM0.00 0%
Total Liquid Assets RM268.67 Million 18.52%

Asset Resilience Insights

  • Good Liquidity Position: Duopharma Biotech Bhd maintains a healthy 18.52% of assets in liquid form.
  • This level provides good financial flexibility while maintaining productive asset deployment.
  • The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Duopharma Biotech Bhd Industry Peers by Asset Resilience Ratio

Compare Duopharma Biotech Bhd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK
Drug Manufacturers - Specialty & Generic 4.94%
Regencell Bioscience Holdings Ltd
NASDAQ:RGC
Drug Manufacturers - Specialty & Generic 43.05%
Changchun High & New Technology Industries Group Inc
SHE:000661
Drug Manufacturers - Specialty & Generic 3.73%
Yuhan Corp.
KO:000100
Drug Manufacturers - Specialty & Generic 0.99%
Tonghua Dongbao Pharmaceutical Co Ltd
SHG:600867
Drug Manufacturers - Specialty & Generic 1.96%
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858
Drug Manufacturers - Specialty & Generic 3.47%
Guangdong Zhongsheng Pharmaceutical Co Ltd
SHE:002317
Drug Manufacturers - Specialty & Generic 6.62%
Guobang Pharma Ltd
SHG:605507
Drug Manufacturers - Specialty & Generic 8.47%

Annual Asset Resilience Ratio for Duopharma Biotech Bhd (2016–2024)

The table below shows the annual Asset Resilience Ratio data for Duopharma Biotech Bhd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 11.71% RM161.25 Million
≈ $40.48 Million
RM1.38 Billion
≈ $345.72 Million
-12.35pp
2023-12-31 24.06% RM323.59 Million
≈ $81.24 Million
RM1.35 Billion
≈ $337.72 Million
+17.71pp
2022-12-31 6.34% RM77.49 Million
≈ $19.46 Million
RM1.22 Billion
≈ $306.78 Million
+3.73pp
2021-12-31 2.62% RM30.45 Million
≈ $7.64 Million
RM1.16 Billion
≈ $292.27 Million
-2.37pp
2020-12-31 4.99% RM52.81 Million
≈ $13.26 Million
RM1.06 Billion
≈ $265.74 Million
+0.46pp
2019-12-31 4.53% RM41.67 Million
≈ $10.46 Million
RM919.80 Million
≈ $230.93 Million
+1.94pp
2018-12-31 2.59% RM21.70 Million
≈ $5.45 Million
RM836.38 Million
≈ $209.99 Million
-4.33pp
2017-12-31 6.93% RM48.86 Million
≈ $12.27 Million
RM705.24 Million
≈ $177.06 Million
-5.84pp
2016-12-31 12.77% RM84.48 Million
≈ $21.21 Million
RM661.46 Million
≈ $166.07 Million
--
pp = percentage points

About Duopharma Biotech Bhd

KLSE:7148 Malaysia Drug Manufacturers - Specialty & Generic
Market Cap
$309.14 Million
RM1.23 Billion MYR
Market Cap Rank
#14832 Global
#171 in Malaysia
Share Price
RM1.28
Change (1 day)
-0.78%
52-Week Range
RM1.21 - RM1.55
All Time High
RM2.86
About

Duopharma Biotech Berhad, an investment holding company, researches, develops, manufactures, distributes, and imports pharmaceutical products and medicines in Malaysia and internationally. The company offers consumer healthcare products, such as vitamins, minerals, and supplements, analgesics, eyecare, antacids, and skin care products; and generic drugs for various therapeutic classes, such as ca… Read more